Related Experiment Videos
Serial Dexamethasone Suppression Tests and Clinical Outcome in ECT
Max Fink1, Krishnareddy Gujavarty, Lawrence Greenberg
1Department of Psychiatry and Behavioral Science, School of Medicine, SUNY at Stony Brook, Long Island, New York, USA.
Convulsive Therapy
|January 1, 1987
Summary
Serial dexamethasone suppression tests (DST) during electroconvulsive therapy did not predict patient outcomes. The DST showed no correlation with clinical improvement, rehospitalization, or suicide risk in severely depressed patients.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Medicine
Background:
- The dexamethasone suppression test (DST) is used to assess hypothalamic-pituitary-adrenal (HPA) axis function.
- Abnormal DST results are common in depression, but their clinical utility during treatment is debated.
Purpose of the Study:
- To investigate the relationship between serial DST results and clinical outcomes in patients undergoing electroconvulsive therapy (ECT).
- To determine if DST can predict treatment response or long-term prognosis in severe depression.
Main Methods:
- Serial DSTs were performed on 43 severely depressed patients during a course of ECT.
- Clinical outcomes, including discharge status and follow-up assessments at six months, were recorded.
- Relationships between initial DST, final DST, and DST changes with clinical measures were analyzed.
Main Results:
- No significant relationships were found between DST results (initial, final, or change) and clinical outcome measures at discharge.
- Follow-up data from 37 patients showed no correlation between DST and continued improvement, rehospitalization, or suicide.
- The DST did not demonstrate predictive value for ECT response or patient prognosis.
Conclusions:
- Serial DSTs are not clinically useful for managing patients receiving electroconvulsive therapy.
- The DST's role in predicting treatment outcomes for severe depression during ECT remains unconfirmed.